Recombinant Human Lactoferrin Augments Epirubicin Chemotherapy in Solid Ehrlich Carcinoma Bearing Mice.

Nahla E El-Ashmawy,Eman G Khedr,Amira Y El-Kady,Ghada M Al-Ashmawy

Current drug safety（2022）

引用 0|浏览2

暂无评分

摘要

Recombinant human lactoferrin exhibited potential anticancer and immuno-enhancing properties in mice with breast cancer. Co-treatment with rhLF and EPI proved to be a promising strategy in cancer treatment.

查看译文

关键词

Breast cancer,Epirubicin,Lactoferrin,Phosphorylated c-Jun N-terminal kinase,Solid Ehrlich carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要